Kidney Disease: Page 2

Momentum builds for tests that predict kidney damage

By Emily Hayes

Pairing the renal angina index (RAI) and urinary neutrophil gelatinase-associated lipocalin (uNGAL) in children seen in intensive care gives a more accurate picture of risk for acute kidney injury, researchers concluded in a study presented on November 9 at the American Society of Nephrology Kidney Week annual meeting in Washington, DC.

November 12, 2019

CAP offers kidney pathology guide in pictures

By LabPulse.com staff writers

The book, titled Medical Kidney Diseases: Morphology-Based Novel Approach to Renal Biopsy, includes instruction on glomerular, vascular tubulointerstitial, and transplant pathology. It is available to CAP members for $64.

October 31, 2019

Electronic health records make case for more kidney function testing

By Emily Hayes

The study included EHRs for 244,540 adult patients treated in the Kaiser Permanente Southern California (KPSC) integrated healthcare delivery system. The researchers found that 58% of patients did not get timely follow-up for incidental abnormal results on estimated glomerular filtration rate (eGFR) tests. This falls far short of expert recommendations for a repeat creatinine test after 90 days to check for chronic kidney disease, reported the team led by Kim Danforth, an epidemiologist and health services researcher at KPSC.

July 16, 2019

RenalytixAI kidney disease blood test gets CPT code

By LabPulse.com staff writers

The company expects that the new CPT Proprietary Laboratory Analyses (PLA) code -- 0105U -- will help the U.S. rollout of its lead product enabled by artificial intelligence (AI). A Medicare payment rate for the new code will be developed through the 2019 Clinical Laboratory Fee Schedule process, and RenalytixAI expects that this will take effect at the beginning of 2020.

June 30, 2019

Researchers link protein group to end-stage renal disease

By Brian Casey

Researchers found that a group of 17 circulating inflammatory proteins were consistently associated with a patient's progression to end-stage renal disease. They believe that the protein group, called the kidney risk inflammatory signature (KRIS), could alert physicians to the chance that a diabetic patient's disease is at risk of progressing.

April 22, 2019